Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 14 studies | 34% ± 15% | |
| microglial cell | 11 studies | 30% ± 12% | |
| macrophage | 9 studies | 26% ± 7% | |
| type II pneumocyte | 9 studies | 34% ± 15% | |
| astrocyte | 6 studies | 23% ± 5% | |
| myeloid cell | 4 studies | 19% ± 5% | |
| glutamatergic neuron | 4 studies | 38% ± 22% | |
| epithelial cell | 3 studies | 34% ± 20% | |
| Mueller cell | 3 studies | 21% ± 3% | |
| GABAergic neuron | 3 studies | 32% ± 11% | |
| oligodendrocyte | 3 studies | 19% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 6 studies | 31% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| skin | 99% | 1436.63 | 1796 / 1809 | 100% | 175.03 | 470 / 472 |
| brain | 100% | 2367.83 | 2638 / 2642 | 95% | 60.33 | 670 / 705 |
| thymus | 100% | 1660.70 | 652 / 653 | 95% | 50.38 | 572 / 605 |
| adrenal gland | 100% | 4263.47 | 258 / 258 | 94% | 45.97 | 216 / 230 |
| lung | 100% | 2198.42 | 578 / 578 | 88% | 29.58 | 1014 / 1155 |
| pancreas | 98% | 1867.48 | 321 / 328 | 89% | 15.82 | 159 / 178 |
| kidney | 99% | 1183.71 | 88 / 89 | 70% | 12.34 | 633 / 901 |
| breast | 99% | 1492.98 | 455 / 459 | 63% | 11.53 | 703 / 1118 |
| stomach | 98% | 879.70 | 351 / 359 | 58% | 11.93 | 166 / 286 |
| esophagus | 86% | 581.53 | 1243 / 1445 | 69% | 21.13 | 127 / 183 |
| uterus | 99% | 925.41 | 168 / 170 | 49% | 16.02 | 223 / 459 |
| intestine | 92% | 593.25 | 893 / 966 | 52% | 10.08 | 273 / 527 |
| bladder | 90% | 580.43 | 19 / 21 | 45% | 9.68 | 228 / 504 |
| ovary | 57% | 300.29 | 103 / 180 | 75% | 22.83 | 322 / 430 |
| prostate | 100% | 1161.00 | 244 / 245 | 20% | 6.18 | 102 / 502 |
| eye | 0% | 0 | 0 / 0 | 100% | 96.57 | 80 / 80 |
| spleen | 100% | 2018.22 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 100% | 1267.21 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1341.39 | 1330 / 1335 | 0% | 0 | 0 / 0 |
| liver | 63% | 385.79 | 142 / 226 | 33% | 5.99 | 136 / 406 |
| muscle | 86% | 1343.55 | 688 / 803 | 0% | 0 | 0 / 0 |
| heart | 82% | 678.39 | 703 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 55% | 9.55 | 16 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 51% | 10.64 | 23 / 45 |
| peripheral blood | 19% | 180.17 | 173 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0060252 | Biological process | positive regulation of glial cell proliferation |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0034599 | Biological process | cellular response to oxidative stress |
| GO_0030154 | Biological process | cell differentiation |
| GO_0048133 | Biological process | male germ-line stem cell asymmetric division |
| GO_0045666 | Biological process | positive regulation of neuron differentiation |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0000976 | Molecular function | transcription cis-regulatory region binding |
| GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
| GO_0003700 | Molecular function | DNA-binding transcription factor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ETV5 |
| Protein name | ETS variant transcription factor 5 ETS translocation variant 5 (Ets-related protein ERM) |
| Synonyms | ERM |
| Description | FUNCTION: Binds to DNA sequences containing the consensus nucleotide core sequence 5'-GGAA.-3'. . |
| Accessions | ENST00000422039.1 ENST00000440773.5 ENST00000434744.5 [P41161-1] C9JR66 C9J0Z2 P41161 C9JMF0 ENST00000413301.5 C9J5A5 ENST00000433149.1 H7C1D2 ENST00000421809.5 ENST00000306376.10 [P41161-1] |